
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) has captured investor interest, showcasing a significant potential upside of 21.41% according to analysts’ average target price projections. As a commercial-stage biopharmaceutical company, Rhythm Pharmaceuticals..
Teva Pharmaceutical Industries (NYSE: TEVA) stands as a formidable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based in Israel, Teva commands a significant..
AptarGroup, Inc. (NYSE: ATR) stands out in the healthcare sector, specifically within the medical instruments and supplies industry, with a robust market capitalization of $8.03 billion. As an investor, understanding..
Roivant Sciences Ltd. (NASDAQ: ROIV), a UK-based biotechnology innovator, has captured investor attention with its ambitious pipeline of therapeutic candidates and a compelling 17.05% potential upside as indicated by analyst..
Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, is gaining attention from investors thanks to its innovative approach to health insurance and a sizable market..
Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector focusing on specialty and generic drug manufacturing, offers a compelling opportunity for investors. With its headquarters in Dublin, Ireland,..
Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, has carved a niche in the medical instruments and supplies industry with a strong focus on women’s health. Headquartered..
For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents an intriguing case. With a market capitalization of $6.06 billion, RadNet has established itself as a prominent..
Moderna, Inc. (MRNA), a beacon in the biotechnology sector, continues to capture investor attention not only due to its groundbreaking work in mRNA medicines but also because of its current..
Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, has garnered attention with its substantial revenue growth despite facing notable challenges in profitability. With a market capitalization..
Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, stands out in the niche market of diagnostic and therapeutic products. With a market capitalization of $4.3 billion,..
Tempus AI, Inc. (NASDAQ: TEM) is carving its path in the healthcare technology sector with a focus on innovative diagnostic and data solutions. Based in Chicago, Illinois, and formerly known..
Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the forefront of the biotechnology sector, pursuing innovative solutions to address debilitating diseases through muscle activators and inhibitors. With a market capitalization of $8.03..
In the rapidly evolving healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a resilient player, delivering impressive growth and promising potential for investors. With a market capitalization..
Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, is drawing significant attention from investors with its promising growth trajectory and robust..
Prestige Consumer Healthcare Inc. (NYSE: PBH) is making waves in the healthcare sector with a promising potential upside of 28.25%. This specialty and generic drug manufacturer, based in Tarrytown, New..
Inspire Medical Systems, Inc. (NYSE: INSP) stands out in the healthcare sector, particularly within the medical devices industry, as a company committed to addressing the prevalent issue of obstructive sleep..
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is making waves in the healthcare sector with a compelling growth trajectory that has caught the attention of investors. As a specialty drug manufacturer, Neurocrine’s..
TransMedics Group, Inc. (TMDX) is capturing the attention of individual investors with its innovative approach to organ transplant therapy. Operating within the healthcare sector, specifically the medical devices industry, TransMedics..
Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is catching the eye of investors with a potential upside of 29.42%. As a key provider of medical..